BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25685803)

  • 1. Intracranial biodegradable silica-based nimodipine drug release implant for treating vasospasm in subarachnoid hemorrhage in an experimental healthy pig and dog model.
    Koskimäki J; Tarkia M; Ahtola-Sätilä T; Saloranta L; Simola O; Forsback AP; Laakso A; Frantzén J
    Biomed Res Int; 2015; 2015():715752. PubMed ID: 25685803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisternal sustained release dihydropyridines for subarachnoid hemorrhage.
    Cook DJ; Kan S; Ai J; Kasuya H; Macdonald RL
    Curr Neurovasc Res; 2012 May; 9(2):139-48. PubMed ID: 22475399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro therapy with dobutamine, isoprenaline and sodium nitroprusside protects vascular smooth muscle metabolism from subarachnoid haemorrhage induced cerebral vasospasm.
    Clark JF; Pyne GJ; Choutka J; Carrozzella JA; Khoury J; Broderick JP; Cadoux-Hudson TA
    Acta Neurochir (Wien); 2001; 143(7):721-8. PubMed ID: 11534694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nimodipine for the prevention of cerebral vasospasm after subarachnoid hemorrhage in 12 children.
    Heffren J; McIntosh AM; Reiter PD
    Pediatr Neurol; 2015 Mar; 52(3):356-60. PubMed ID: 25585913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aneurysmal Subarachnoid Hemorrhage: Strategies for Preventing Vasospasm in the Intensive Care Unit.
    Diringer MN; Zazulia AR
    Semin Respir Crit Care Med; 2017 Dec; 38(6):760-767. PubMed ID: 29262433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The efficacy and safety of the nicardipine prolonged-release implant in a canine double hemorrhage model].
    Sasahara A; Kasuya H; Kawashima A; Aihara Y; Izawa M; Hori T
    No Shinkei Geka; 2000 Dec; 28(12):1071-5. PubMed ID: 11193527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local delivery of nimodipine by prolonged-release microparticles-feasibility, effectiveness and dose-finding in experimental subarachnoid hemorrhage.
    Hänggi D; Perrin J; Eicker S; Beseoglu K; Etminan N; Kamp MA; Heiroth HJ; Bege N; Macht S; Frauenknecht K; Sommer C; Kissel T; Steiger HJ
    PLoS One; 2012; 7(9):e42597. PubMed ID: 23049732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption, elimination and cerebrospinal fluid concentrations of nimodipine in healthy beagle dogs receiving human intravenous and oral formulation.
    Koskimäki J; Tarkia M; Ahtola-Sätilä T; Saloranta L; Laakso A; Frantzén J
    Eur J Drug Metab Pharmacokinet; 2016 Jun; 41(3):295-300. PubMed ID: 25652785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of intraoperative continuous nimodipine infusion on cerebral vasospasm during intracranial aneurysm surgery].
    Han RQ; Wang BG; Li SR; Wang EZ; Liu W; Wang S; Zhao JZ
    Zhonghua Wai Ke Za Zhi; 2004 Dec; 42(24):1489-92. PubMed ID: 15733479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ forming nimodipine depot system based on microparticles for the treatment of posthemorrhagic cerebral vasospasm.
    Bege N; Renette T; Endres T; Beck-Broichsitter M; Hänggi D; Kissel T
    Eur J Pharm Biopharm; 2013 May; 84(1):99-105. PubMed ID: 23298622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter by Rustemi Regarding Article, "Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage])".
    Rustemi O
    Stroke; 2017 Apr; 48(4):e113. PubMed ID: 28283604
    [No Abstract]   [Full Text] [Related]  

  • 14. Response by Hänggi and Macdonald to Letter Regarding Article, "Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage])".
    Hänggi D; Macdonald RL
    Stroke; 2017 Apr; 48(4):e114. PubMed ID: 28283608
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of controlled-release papaverine pellets in preventing symptomatic cerebral vasospasm.
    Dalbasti T; Karabiyikoglu M; Ozdamar N; Oktar N; Cagli S
    J Neurosurg; 2001 Jul; 95(1):44-50. PubMed ID: 11453397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of nimodipine and deferoxamine on brain injury in rat with subarachnoid hemorrhage.
    Qin Y; Li G; Sun Z; Xu X; Gu J; Gao F
    Behav Brain Res; 2019 Jul; 367():194-200. PubMed ID: 30953658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic Modeling of Intra-arterial Nimodipine Therapy for Subarachnoid Hemorrhage-Related Cerebral Vasospasm.
    Seker F; Hesser J; Brockmann MA; Neumaier-Probst E; Groden C; Schubert R; Brockmann C
    Clin Neuroradiol; 2017 Jun; 27(2):199-203. PubMed ID: 26350588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Site-Specific, Sustained-Release Drug Delivery System for Aneurysmal Subarachnoid Hemorrhage.
    Hänggi D; Etminan N; Steiger HJ; Johnson M; Peet MM; Tice T; Burton K; Hudson B; Turner M; Stella A; Heshmati P; Davis C; Faleck HJ; Macdonald RL
    Neurotherapeutics; 2016 Apr; 13(2):439-49. PubMed ID: 26935204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of intravenous cilostazol and nimodipine on cerebral vasospasm after subarachnoid hemorrhage in an experimental rabbit model.
    Bilginer B; Onal MB; Narin F; Soylemezoglu F; Ziyal IM; Ozgen T
    Turk Neurosurg; 2009 Oct; 19(4):374-9. PubMed ID: 19847758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of nimodipine on rabbits with symptomatic cerebral vasospasm].
    Yu JM; Mo YC; Liang DD; Tao F; Geng WJ; Wang JL
    Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(5):345-9. PubMed ID: 21419013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.